Clinical Trial Update: This Study Include Chronic Obstructive Pulmonary Disease(COPD) Patients . Patients Were Vitamin D Deficient Age Range 40 to 80 Years, Smokers Patients Were Advised to Take Either Placebo or Vitamin D3 . Antioxidant Enzymes Were Assessed at Baseline and at 26th Weeks. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing vitamin D3 versus placebo in vitamin D deficient COPD patients, with antioxidant enzymes measured over 26 weeks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: UNKNOWN